A study published in 2018 [60] targeted the gastric adenocarcinoma cell line AGS with anti-CDH17, an antibody against the extracellular domain of Cadherin-17 (CDH17), which is expressed in gastric cancer. Here, CDH17 is linked to gastric adenocarcinoma.